Newsletter Subscription

Thursday, May 5, 2016

SELEX Galileo signs 17M EUR contract for SIMBIO-SYS phase B2/C/D

  • for the BepiColombo space mission
Rome - SELEX Galileo, a Finmeccanica Company, has signed a contract worth over 17 million Euros with the Italian Space Agency (Agenzia Spaziale Italiana, ASI) for the development and production of the SIMBIO-SYS instrument for the European Space Agency (ESA)'s BepiColombo mission. The total value of contracts awarded to SELEX Galileo for the SYMBIO-SYS exceeds 33 million Euros.

BepiColombo is an unmanned mission to Mercury to observe the planet and surrounding environment, and is one of the cornerstones of the ESA's long-term science programme. The mission comprises two satellites, one of which, the Mercury Platen Orbiter (MPO), is being built by ESA to study the surface and internal composition of the planet.

Related Research on
The Global Soldier Modernization Market 2015-2025

SELEX Galileo's SYMBIO-SYS has been designed for installation on board the MPO satellite. The name stands for 'Spectrometers and Imagers for MPO BepiColombo Integrated Observatory System'; SELEX Galileo began development of the system back in 2007 with preliminary design work and the purchase of critical components.

The instrument has three optical channels for the remote observation of Mercury including a spectrometer, a high resolution camera, and a stereo channel for the construction of 3D maps. The data gathered by the sensors will be managed by three INAF Institutes: INAFIASF, INAF-OAC and INAF-OAPD.

Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.

Source : Selex Galileo

Published on ASDNews: Jan 28, 2011


ITAR/EAR Boot Camp-2 days Seminar

Sep 14 - 15, 2016 - Annapolis, United States

Register More info

Mobile MILSATCOM 2016 conference

Aug 30 - 31, 2016 - London, United Kingdom

Register More info

© 2004-2016 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs